Osteomalacia News and Articles

Return to Library

Recent Osteomalacia News and Articles

• Research Conducted at Tufts University Has Provided New Information about Orthopedics
• Researchers at University of Nebraska Have Published New Data on Spinal Disorders
• New HIV/AIDS Research from Hospital Clinic Outlined
• Patent Issued for Combination Dosage Forms and Therapies for Supporting Bone Health
• Patent Issued for Methods and Compositions for Improving the Nutritional Content of Mushrooms and Fungi
• Research from University of Tennessee Health Science Center Yields New Data on Molecular Endocrinology
• Investigators at University of Connecticut Health Center Zero in on Hypophosphatemia
• Patent Issued for Use of Notch Signaling Regulators for Modulating Osteogenesis
• New Clinical Investigation Findings from Indiana University School of Medicine Described

---

New Osteomalacia Research Reported from University Hospital

2013 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Metabolic Bone Diseases have been published. According to news reporting out of Angers, France, by NewsRx editors, research stated, "A 93 year-old woman with Paget's disease of bone had been treated with etidronate without interruption during 20 years. The daily dose was usual (5mg/kg/day) but this prescription had never been stopped by her physicians."

Our news journalists obtained a quote from the research from University Hospital, "Two fractures had already occurred in pagetic (right tibia) and non pagetic bones (right fibula) within the last 2 years, and she presented rib fractures, another right tibia fracture and right femur fracture during hospitalization time. X-rays films showed major osteolysis of left ulna and right tibia. Blood samples and technetium bone scan brought no evidence for sarcoma or lytic evolution of the disease. A transiliac bone biopsy on non pagetic bone site confirmed the diagnosis of osteomalacia (increased osteoid parameters), with secondary hyperparathyroidism (hook resorption). In Paget's disease of bone, continuous treatment by etidronate may induce generalized osteomalacia, and increase the risk of fracture in both pagetic and non-pagetic bones."

According to the news editors, the research concluded: "Whereas physicians and pharmaceutical industry try to improve the observance of those drugs, this striking observation also points out that a prescription always needs to be updated."

For more information on this research see: Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate. Morphologie, 2012;96(313):40-3. (Elsevier - www.elsevier.com; Morphologie - www.elsevier.com/wps/product/cws_home/709671)

Our news journalists report that additional information may be obtained by contacting E. Hoppe, Service de rhumatologie, CHU, 49933 Angers cedex, France.

Keywords for this news article include: Angers, France, Europe, Osteomalacia, Bone Research, Metabolic Bone Diseases, Musculoskeletal Diseases.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC